A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. D'Amico E, Messina S, Caserta C, Patti F Expert Opin Drug Saf. 2015 Mar 31:1-12. PMID: 25826609. Abstract CommentRecommendBookmarkWatch